One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2021-145128
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 5 |
Affiliation: Harvard University, Massachusetts General Hospital, Hammersmith Hospital, Erasmus MC, Østfold Hospital Trust, Sanofi (Turkey), University of Washington Medical Center, Murdoch University, Sanofi (United States), Leicester Royal Infirmary, University Hospital Dr. Georgi Stranski, Principia Biopharma (United States), University Hospital St. Marina, Monash Medical Centre, Barts Health NHS Trust, Royal London Hospital, University Hospital Ostrava, University of Ostrava, Canberra Hospital, University Hospital Hradec Králové, University Hospital Brno, Masaryk University, Princess Alexandra HospitalUpdated Phase I/II Safety and Efficacy Results for Oral Bruton Tyrosine Kinase Inhibitor Rilzabrutinib in Patients with Relapsed/Refractory Immune Thrombocytopenia
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
